Gene · 1633
Papers2,658
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,658
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Noncoding RNAs: an emerging modulator of drug resistance in pancreatic cancer. | Front Cell Dev Biol | 2023 | 37560164 | PubTator, text mining | PubMed |
| Molecular signature associated with cladribine treatment in patients with multiple sclerosis. | Front Immunol | 2023 | 37559720 | PubTator, text mining | PubMed |
| Inborn Errors of Purine Salvage and Catabolism. | Metabolites | 2023 | 37512494 | PubTator, text mining | PubMed |
Tiliacora triandra Leaf Powder Ethanolic Extract in Combination with Cisplatin or Gemcitabine Synergistically Inhibits the Growth of Cholangiocarcinoma Cells In Vitro and in Nude Mouse Xenograft Models. | Medicina (Kaunas) | 2023 | 37512080 | PubTator, text mining | PubMed |
| Therapeutic Targeting of RNA Splicing in Cancer. | Genes (Basel) | 2023 | 37510283 | PubTator, text mining | PubMed |
| Targeting pan-essential pathways in cancer with cytotoxic chemotherapy: challenges and opportunities. | Cancer Chemother Pharmacol | 2023 | 37452860 | PubTator, text mining | PubMed |
| The impact of hypoxia-inducible factors in the pathogenesis of kidney diseases: a link through cell metabolism. | Kidney Res Clin Pract | 2023 | 37448286 | PubTator, text mining | PubMed |
| PTEN deficiency facilitates gemcitabine efficacy in cancer by modulating the phosphorylation of PP2Ac and DCK. | Sci Transl Med | 2023 | 37437018 | PubTator, text mining | PubMed |
| Multiple sclerosis patients treated with cladribine tablets: expert opinion on practical management after year 4. | Ther Adv Neurol Disord | 2023 | 37434878 | PubTator, text mining | PubMed |
| Cladribine Tablets Mode of Action, Learning from the Pandemic: A Narrative Review. | Neurol Ther | 2023 | 37421556 | PubTator, text mining | PubMed |
| Vpx requires active cellular dNTP biosynthesis to effectively counteract the anti-lentivirus activity of SAMHD1 in macrophages. | J Biol Chem | 2023 | 37390988 | PubTator, text mining | PubMed |
| Safety Assessment of a Nucleoside Analogue FNC (2'-deoxy-2'- β-fluoro-4'-azidocytidine ) in Balb/c Mice: Acute Toxicity Study. | Asian Pac J Cancer Prev | 2023 | 37378948 | PubTator, text mining | PubMed |
| DCK confers sensitivity of DCTD-positive cancer cells to oxidized methylcytidines. | Protein Cell | 2023 | 37378658 | PubTator, text mining | PubMed |
| Clinical and bi-genomic DNA findings of patients suspected to have mitochondrial diseases. | Front Genet | 2023 | 37377599 | PubTator, text mining | PubMed |
| Insights on the Role of Polyphenols in Combating Cancer Drug Resistance. | Biomedicines | 2023 | 37371804 | PubTator, text mining | PubMed |
| Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy. | Cancers (Basel) | 2023 | 37370755 | PubTator, text mining | PubMed |
| [Pancytopenia in children caused by SAMD9/9L mutation: 5 cases report and literature review]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 37357006 | PubTator, text mining | PubMed |
| DNA methyltransferase inhibitor exposure-response: Challenges and opportunities. | Clin Transl Sci | 2023 | 37345219 | PubTator, text mining | PubMed |
| The crisscross between p53 and metabolism in cancer. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37337630 | PubTator, text mining | PubMed |
| ATR kinase supports normal proliferation in the early S phase by preventing replication resource exhaustion. | Nat Commun | 2023 | 37336885 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1633/papers?page=7